Finalists invited to pitch ideas to panel of judges including Robert Herjavec, technology entrepreneur, passionate cancer caregiver and star of
ABC’s Emmy Award-winning hit television show Shark Tank
BOSTON, April 25, 2016 – Astellas Pharma Inc. (TSE: 4503) today launched the C3 PrizeTM, a challenge designed to inspire non-medicine innovations that improve the cancer care experience for patients, caregivers and loved ones. Entries will be accepted through August 8 and following a live pitch to a panel of judges including Robert Herjavec, star of ABC’s Emmy Award-winning hit television show Shark Tank, three winners will be awarded a total of $100,000 in grants as well as membership to healthcare technology incubator MATTER to bring their ideas to life. The C3 Prize was announced today to a group of 1,100 global leaders in cancer care gathered at the World Medical Innovation Forum organized by Partners HealthCare.
By 2030, the global cancer burden is expected to grow to 22.2 million cancer cases.1 Despite significant advances in cancer treatments, patients with cancer and their caregivers face significant obstacles to receiving or providing optimal care through all phases of living with cancer.
“As the number of people diagnosed with cancer rises, so does the need for innovative tools and resources to help patients and those that care for them navigate the journey from diagnosis to hopefully survivorship,” said Mark Reisenauer, senior vice president, oncology sales and marketing, Astellas. “We’re launching the C3 Prize because we want to hear fresh ideas and perspectives from people who want to make a difference in the lives of those living with cancer.”
The C3 Prize seeks submissions in four areas where patients living with cancer and the cancer community face the toughest obstacles along the cancer continuum: navigating the health care system, adhering to complex medical care requirements, coordinating care and surviving life post-treatment.
Five finalists will be invited to pitch their ideas in front of a live panel of judges including Herjavec at the Stanford Medicine X conference on September 17, 2016 in Stanford, California.
C3 Prize submissions can be made at C3Prize.com and are due by midnight Central Time on August 8, 2016. Entries will be evaluated based on plausibility of idea, creativity and originality of innovation and the ability of the entrant to operationalize/implement the innovative idea for future application.